REIMAGINE YOUNG: Efficacy and Safety of Cagrilinitide and Semaglutide (CagriSema) s.c. once weekly versus placebo in children and adolescents with type 2 diabetes (NN9388-7988)

Project: Research

Status	Active
Effective start/end date	08/6/26 → 02/4/28

Project Details